Related Experiment Video
Updated: Jun 21, 2026

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
Published on: September 28, 2022
Epstein-Barr virus in multiple sclerosis
1Department of Neurology, 1542 Tulane Avenue, Room 718B, Louisiana State University Health Science Center, New Orleans, LA 70112, USA. bbager@lsuhsc.edu
Abstract:
Recent seroepidemiologic and pathologic evidence suggests that prior infection with Epstein-Barr virus (EBV) may be necessary for the development of multiple sclerosis (MS). EBV infects more than 90% of all humans, most of whom remain healthy. In contrast, 99% of MS patients have evidence of prior infection with EBV. EBV infects resting B lymphocytes, immortalizing them into long-lived memory B cells that survive largely undetected by the immune system in the peripheral circulation. MS patients show elevated titers to EBV years before developing any neurologic symptoms. Postmortem pathologic analysis of brains of patients with MS has revealed diffuse EBV-associated B-cell dysregulation in all forms of MS. Theories of pathogenesis of EBV in MS include antigenic mimicry, immortalization of B-cell clones, and cytotoxic T-cell dysfunction against virally infected B cells. This article reviews the existing evidence of the relationship between EBV and MS and considers the therapeutic implication of this evidence.
Insights
Prior Epstein-Barr virus (EBV) infection is strongly linked to developing multiple sclerosis (MS). Most people get EBV, but 99% of MS patients show evidence of prior EBV infection, suggesting a necessary role.
Area of Science:
- Neuroimmunology
- Virology
- Epidemiology
Background:
- Epstein-Barr virus (EBV) infects over 90% of the global population, typically remaining latent.
- A high prevalence of prior EBV infection is observed in multiple sclerosis (MS) patients (99%) compared to the general population.
- EBV establishes lifelong infection in memory B lymphocytes, evading immune detection.
Purpose of the Study:
- To review the evidence linking Epstein-Barr virus (EBV) to the pathogenesis of multiple sclerosis (MS).
- To explore potential mechanisms by which EBV may contribute to MS development.
- To consider the therapeutic implications of the EBV-MS relationship.
Main Methods:
- Review of seroepidemiologic studies correlating EBV infection rates with MS.
- Analysis of pathologic findings in postmortem MS brain tissue.
- Examination of proposed pathogenetic theories including antigenic mimicry and B-cell dysregulation.
Main Results:
- Elevated EBV antibody titers are detected in MS patients years preceding neurological symptoms.
- Postmortem analyses reveal widespread EBV-associated B-cell abnormalities in all forms of MS.
- Strong correlation between prior EBV infection and MS development.
Conclusions:
- Prior Epstein-Barr virus infection is strongly suggested as a necessary factor in multiple sclerosis development.
- EBV-associated B-cell immortalization and immune dysregulation are key proposed mechanisms.
- Understanding the EBV-MS link offers potential avenues for novel MS therapies.
More Related Videos
08:44Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
09:43An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
Published on: March 30, 2018
Related Concept Videos
Multiple Sclerosis l: Introduction
Arboviral Encephalitis
Encephalitis ll: Pathophysiology
Cytomegalovirus Disease
Encephalitis l: Introduction